These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 38179952)

  • 1. Application of 24-h respiratory rate and oxygenation index variation to predict the outcome of high-flow nasal cannula therapy in patients with acute hypoxemic respiratory failure in a respiratory intensive care unit.
    Ge J; Zhou D; Wang Y; Ning W; Zhang B; Chen C
    Biomark Med; 2023 Oct; 17(20):859-869. PubMed ID: 38179952
    [No Abstract]   [Full Text] [Related]  

  • 2. Respiratory rate‑oxygenation (ROX) index for predicting high-flow nasal cannula failure in patients with and without COVID-19.
    Kwon H; Ha SW; Kim B; Chae B; Kim SM; Hong SI; Kim JS; Kim YJ; Ryoo SM; Kim WY
    Am J Emerg Med; 2024 Jan; 75():53-58. PubMed ID: 37913715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The ROX index as a predictor of high-flow nasal cannula outcome in pneumonia patients with acute hypoxemic respiratory failure: a systematic review and meta-analysis.
    Zhou X; Liu J; Pan J; Xu Z; Xu J
    BMC Pulm Med; 2022 Apr; 22(1):121. PubMed ID: 35365110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of high-flow nasal cannula outcomes at the early phase using the modified respiratory rate oxygenation index.
    Li Z; Chen C; Tan Z; Yao Y; Xing S; Li Y; Gao Y; Zhao Z; Deng Y; Zhu M
    BMC Pulm Med; 2022 Jun; 22(1):227. PubMed ID: 35698120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Respiratory Rate Oxygenation (ROX) index as predictor of high flow nasal cannula in pediatric patients in pediatric intensive care unit.
    Yuniar I; Pudjiadi AH; Dewi R; Prawira Y; Puspaningtyas NW; Tartila T; Fulki S
    BMC Pulm Med; 2024 May; 24(1):216. PubMed ID: 38698400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COVID-19 Pneumonia and ROX index: Time to set a new threshold for patients admitted outside the ICU.
    Vega ML; Dongilli R; Olaizola G; Colaianni N; Sayat MC; Pisani L; Romagnoli M; Spoladore G; Prediletto I; Montiel G; Nava S
    Pulmonology; 2022; 28(1):13-17. PubMed ID: 34049831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Analysis of ROX Index, ROX-HR Index, and SpO
    Choi SH; Kim DY; Song BY; Yoo YS
    J Korean Acad Nurs; 2023 Aug; 53(4):468-479. PubMed ID: 37673820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retrospective evaluation of the respiratory rate-oxygenation index to predict the outcome of high-flow nasal cannula oxygen therapy in dogs (2018-2021): 81 cases.
    Eicher L; Young AA; Hoover L; Kuo KW; Her J
    J Vet Emerg Crit Care (San Antonio); 2024; 34(3):252-261. PubMed ID: 38708968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Failure Prediction of High-Flow Nasal Cannula at the Conventional Oxygen Therapy Phase in the Emergency Department.
    Kang Y; Jung HM; Chung SP; Chung HS; Cho Y
    Respiration; 2024; 103(8):488-495. PubMed ID: 38934166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ROX (Respiratory rate-OXygenation) index to predict early response to high-flow nasal cannula therapy in infants with viral bronchiolitis.
    Milesi C; Nogue E; Baleine J; Moulis L; Pouyau R; Gavotto A; Brossier D; Mortamet G; Cambonie G;
    Pediatr Pulmonol; 2024 Apr; 59(4):982-990. PubMed ID: 38197495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reliability of the respiratory rate and oxygenation index for successful high-flow nasal cannula support in coronavirus disease pneumonia: a retrospective cohort study.
    Hirabayashi R; Nagata K; Sato Y; Nakagawa A; Tachikawa R; Kuroda H; Seo R; Morimoto T; Tomii K
    BMC Pulm Med; 2023 Aug; 23(1):294. PubMed ID: 37559018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ratio of oxygen saturation index for predicting high-flow nasal cannula outcomes in emergency department for COVID-19 patients with severe hypoxemia: A retrospective study.
    Karam C; Oseili A; Shebbo FM; Fakih M; El-Khatib MF
    Turk J Emerg Med; 2024; 24(1):41-47. PubMed ID: 38343517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predicting the successful application of high-flow nasal oxygen cannula in patients with COVID-19 respiratory failure: a retrospective analysis.
    Yu PT; Chen CH; Wang CJ; Kuo KC; Wu JC; Chung HP; Chen YT; Tang YH; Chang WK; Lin CY; Wu CL
    Expert Rev Respir Med; 2023 Apr; 17(4):319-328. PubMed ID: 37002880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predicting success of high-flow nasal cannula in pneumonia patients with hypoxemic respiratory failure: The utility of the ROX index.
    Roca O; Messika J; Caralt B; García-de-Acilu M; Sztrymf B; Ricard JD; Masclans JR
    J Crit Care; 2016 Oct; 35():200-5. PubMed ID: 27481760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Noninvasive ventilation and high-flow nasal cannula in patients with acute hypoxemic respiratory failure by covid-19: A retrospective study of the feasibility, safety and outcomes.
    Costa WNDS; Miguel JP; Prado FDS; Lula LHSM; Amarante GAJ; Righetti RF; Yamaguti WP
    Respir Physiol Neurobiol; 2022 Apr; 298():103842. PubMed ID: 35026479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sequential application of oxygen therapy via high-flow nasal cannula and noninvasive ventilation in acute respiratory failure: an observational pilot study.
    Frat JP; Brugiere B; Ragot S; Chatellier D; Veinstein A; Goudet V; Coudroy R; Petitpas F; Robert R; Thille AW; Girault C
    Respir Care; 2015 Feb; 60(2):170-8. PubMed ID: 25294935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of respiratory rate-oxygenation index to predict failure of high-flow nasal cannula in patients with coronavirus disease 2019-associated acute respiratory distress syndrome: A retrospective study.
    Poopipatpab S; Nuchpramool P; Phairatwet P; Lertwattanachai T; Trongtrakul K
    PLoS One; 2023; 18(6):e0287432. PubMed ID: 37343046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Choice of respiratory therapy for COVID-19 patients with acute hypoxemic respiratory failure: a retrospective case series study.
    Sudo K; Sawa T; Kushimoto K; Yoshii R; Yuasa K; Inoue K; Kinoshita M; Yamasaki M; Kooguchi K
    PeerJ; 2023; 11():e15174. PubMed ID: 37065694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expanding the utility of the ROX index among patients with acute hypoxemic respiratory failure.
    Li A; Cove ME; Phua J; Puah SH; Ng V; Kansal A; Tan QL; Sahagun JT; Taculod J; Tan AY; Mukhopadhyay A; Tay CK; Ramanathan K; Chia YW; Sewa DW; Chew M; Lew SJW; Goh S; Dhanvijay S; Tan JJ; See KC;
    PLoS One; 2022; 17(4):e0261234. PubMed ID: 35472205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ROX index as predictor of high flow nasal cannula therapy success in acute respiratory failure due to SARS-CoV-2.
    Ferrer S; Sancho J; Bocigas I; Bures E; Mora H; Monclou E; Mulet A; Quezada A; Royo P; Signes-Costa J
    Respir Med; 2021; 189():106638. PubMed ID: 34634500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.